iRhom2 may play a critical role in the pathogenesis of acute lung injury (ALI) after intestinal I/R and thus may be a novel therapeutic target for ALI after intestinal I/R injury. This evidence concerns the gene RHBDF2 and acute respiratory distress syndrome.